🩹 Healing & RecoveryWidely Used

KLOW Peptide Blend

Klow Stack · GHK-Cu + KPV + BPC-157 + TB-500 · Immune Repair Peptide Blend

A 4-peptide blend combining GHK-Cu, KPV, BPC-157, and TB-500 for tissue repair, immune modulation, GI health, and musculoskeletal recovery.

Typical Dose

KPV 500 mcg-1 mg + GHK-Cu 1-2 mg + BPC-157 500 mcg-1 mg + TB-500 2.5 mg per injection

Route

Subcutaneous

Frequency

3-5x per week (loading phase), 2-3x per week (maintenance)

Cycle

8-12 week cycles with 4-week breaks

Overview

KLOW is a 4-compound injectable peptide blend designed for people dealing with more complex healing challenges - particularly those involving immune dysregulation, chronic inflammation, gut issues, or musculoskeletal injuries. It builds on the GLOW stack (GHK-Cu + BPC-157 + TB-500) by adding KPV, a tripeptide derived from alpha-MSH (alpha-melanocyte-stimulating hormone) that has potent anti-inflammatory and immune-modulating properties. KPV is particularly well-studied for inflammatory bowel conditions, skin inflammation, and systemic immune regulation. Together, the four compounds in KLOW address tissue repair (BPC-157), systemic recovery (TB-500), collagen and skin health (GHK-Cu), and immune/inflammatory control (KPV) - making it one of the most comprehensive healing stacks available.

Key Benefits

Modulates immune response and reduces chronic inflammation
Supports healing of inflammatory bowel conditions (IBD, Crohn's, colitis)
Accelerates tissue repair in muscles, tendons, and ligaments
Boosts collagen and elastin production for skin and joint health
Reduces systemic and localized inflammation
Promotes new blood vessel formation for improved healing
Supports gut mucosal healing and barrier integrity
Improves skin conditions linked to immune dysregulation

Mechanism of Action

KLOW works through four synergistic pathways. KPV acts on melanocortin receptors (MC1R and MC3R) in immune cells and gut epithelium to suppress pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1beta - essentially turning down the volume on runaway inflammation. GHK-Cu activates over 4,000 genes involved in skin repair, collagen synthesis, and anti-inflammatory signaling. BPC-157 promotes angiogenesis, upregulates growth hormone receptors in connective tissue, and modulates nitric oxide pathways to accelerate local repair. TB-500 upregulates actin to improve cell migration and systemic recovery. The addition of KPV to the GLOW stack is what makes KLOW particularly effective for immune-related conditions and gut health.

Dosing Protocol

Typical Dose

KPV 500 mcg-1 mg + GHK-Cu 1-2 mg + BPC-157 500 mcg-1 mg + TB-500 2.5 mg per injection

Dose Range

KPV 250 mcg-2 mg | GHK-Cu 1-2 mg | BPC-157 250 mcg-1 mg | TB-500 2-5 mg

Frequency

3-5x per week (loading phase), 2-3x per week (maintenance)

Route

Subcutaneous injection; for GI conditions, oral KPV may be used alongside injectable components

Cycle Length

8-12 week cycles with 4-week breaks

CLINICAL NOTES

For inflammatory bowel conditions, some practitioners use oral KPV separately while injecting the remaining three compounds. Reconstitute each component separately unless using a pre-blended vial. Rotate injection sites. Medical supervision is strongly recommended given the immune-modulating effects of KPV.

Save to Library

Reconstitution calculator and cycle planner pre-filled with KLOW Peptide Blend defaults

Side Effects & Safety

Temporary redness or irritation at injection site
Mild nausea (usually resolves within the first week)
Fatigue or sedation in the first few days (KPV effect)
Flushing or warmth sensation (from GHK-Cu)
Potential immune modulation effects - monitor if on immunosuppressants
Darkening of existing moles or skin pigmentation (rare - monitor closely)

IMPORTANT DISCLAIMER

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.

Research References

Frequently Asked Questions

Quick Reference

CategoryHealing & Recovery
Research StatusWidely Used
Typical DoseKPV 500 mcg-1 mg + GHK-Cu 1-2 mg + BPC-157 500 mcg-1 mg + TB-500 2.5 mg per injection
RouteSubcutaneous
Cycle8-12 week cycles with 4-week breaks

Community Reviews

Real experiences from the Peptide Insights community

Have experience with KLOW Peptide Blend?

Log in to share your experience and help the community.

Log In to Review

No reviews yet for KLOW Peptide Blend

Be the first to share your experience.

Free Guide

Want to go deeper on KLOW Peptide Blend?

Get our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.

Free Beginner's Guide

32-page PDF, instant download

No spam. Unsubscribe anytime.